Antonello Mai

89PUBLICATIONS
269CO-AUTHORS
Biologically active moleculesGene and molecular therapyNeurology and neuromuscular diseasesCheminformatics and quantitative structure-activity relationshipsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (89)

|Sep 15, 2026
Molecular Striptease of a Thiadiazolopyrimidine Hit Yields a Streamlined, Artifact-Free NADPH Mimic for NOX Inhibition.

|Jul 20, 2026
METTL1/WDR4 Complex: A Novel Epitranscriptomic Target at the Crossroads of RNA Methylation and Drug Discovery.

|Jul 16, 2026
Mutant Huntingtin disrupts neurogenic and astroglial programs via the EZH2-Let-7g-LIN28 axis with rescue by epigenetic modulators.

|May 05, 2026
Development of High-Affinity CHD1 Chromodomain Inhibitors.

|Apr 30, 2026
Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.

|Mar 27, 2026
A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.

Nesteene Joy Param, Elisa Arceci, Francesco Fiorentino

Pageof 15

Frequent Collaborators

43 joint publications

Dante Rotili

31 joint publications

Sergio Valente

26 joint publications

Francesco Fiorentino

19 joint publications

Clemens Zwergel